Previous studies reported that adults with growth hormone deficiency in which hepatic IGF-1 production is impaired exhibit an increased prevalence of NASH; IGF-1 substitution ameliorated NAFLD in a mouse model [96, 97]. This evidence concerns the gene IGF1 and metabolic dysfunction-associated steatotic liver disease.